Find your next paid study

Actual pay is set by the research site.

Mayo ClinicNCT07659158

Metastatic Malignant Solid NeoplasmPlatinum-Resistant Ovarian High Grade Serous AdenocarcinomaUnresectable Malignant Solid Neoplasm

A Phase I Study of DS-8201a in Combination With Olaparib in HER2-Expressing Malignancies

This phase I trial identifies the side effects and best dose of DS-8201a and olaparib in treating patients with HER2-expressing cancers that have spread to oth…

National Cancer Institute (NCI)NCT04585958

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

The goal of this clinical trial is to learn how atorvastatin in patients with advanced high grade serous cancer of the ovary, fallopian tube, or peritoneum cha…

Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer+1 more

University of Colorado, DenverNCT07815704

~$75 – $2,000

Actual pay is set by the research site.

Pancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerColorectal Cancer+2 more

A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients With Advanced KRAS G12D-Mutated Solid Tumors

This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.

Verastem, Inc.NCT07020221

~$150 – $4,200

Actual pay is set by the research site.

Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

The SCORE-NMIBC study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with non-muscle Invasiv…

Non-Muscle Invasive Bladder CancerNMIBCHigh-risk Non-Muscle Invasive Bladder Cancer

~$10 – $1,050

Actual pay is set by the research site.

Natera, Inc.NCT07763197

Depression in AdolescenceObesity & OverweightCognitive-behavioral Therapy+2 more

Digitally Enhanced Cognitive-Behavioral Therapy for Adolescents With Depression and Obesity

Adolescent depression is a major public health problem. Depression affects adolescents' emotional well-being now and in the future, and it also affects their p…

Colorado State UniversityNCT07569991

Actual pay is set by the research site.

Phase 2

Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable Squamous Cell Carcinoma of the Head and Neck: a Phase 2 Trial

This trial is to evaluate the safety and efficacy of ficerafusp alfa in combination with pembrolizumab prior to surgical resection in participants with resecta…

Head and Neck Squamous Cell Carcinoma (HNSCC)Squamous Cell Carcinoma of the Head and Neck

Dana-Farber Cancer InstituteNCT07465276

~$75 – $3,000

Actual pay is set by the research site.

Urinary Bladder, NeurogenicUrodynamics

Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing

The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters. The investigators will be testing how the pressur…

Christopher CooperNCT03456089

~$10 – $1,125

Actual pay is set by the research site.

Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, sympto…

Massachusetts General HospitalNCT05237258

Actual pay is set by the research site.

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more

Phase I Study of Adoptive Immunotherapy of Refractory Viral Infection With ex Vivo Expanded Rapidly Generated Virus Specific T (R-MVST) Cells

The primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomati…

Columbia UniversityNCT05183490

~$150 – $3,000

Actual pay is set by the research site.

Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+4 more

A Dose Escalation and Dose Optimization Phase 1a/1b Study to Evaluate Safety, Tolerability and Dosimetry of Radioligand Therapy With LY4337713 in Adults With FAP-Positive Solid Tumors (FiREBOLT)

This is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a p…

Eli Lilly and CompanyNCT07213791

~$150 – $4,500

Actual pay is set by the research site.

AutismChallenging BehaviorADHD+1 more

RCT of a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health

The goal of this clinical trial is to test whether a smartphone-based data collection and feedback application ("Footsteps") improves the quality of behavioral…